HomeInsightsResults

Zydus Lifesciences Ltd Quarterly Result

Zydus Lifesciences Ltd Quarterly Result

stocks purchased

₹ 5.3 Cr

Volume Transacted

(Dec 20, 2024)

stocks purchased

54.0 K

Stocks Traded

(Dec 20, 2024)

Last Updated on: Dec 23, 2024

Image

Zydus Lifesciences Ltd

NSE: ZYDUSLIFE

Net Profit

₹ 898.1

Last updated on: Dec 23, 2024

Key Highlights

  • The revenue of Zydus Lifesciences Ltd for the Sep '24 is ₹ 5305 crore as compare to the Jun '24 revenue of ₹ 6270 crore. This represent the decline of -15.392223%.
  • The ebitda of Zydus Lifesciences Ltd for the Sep '24 is ₹ 1529 crore as compare to the Jun '24 ebitda of ₹ 2147 crore. This represent the decline of -28.749065%.
  • The net profit of Zydus Lifesciences Ltd for the Sep '24 is ₹ 898.1 crore as compare to the Jun '24 net profit of ₹ 1463 crore. This represent the decline of -38.637608%.

Results Analysis

Market Price of Zydus Lifesciences Ltd

1M

1Y

3Y

5Y

Monitoring Zydus Lifesciences Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
20 Dec 2024973.9
19 Dec 2024985.7
18 Dec 2024979.1
17 Dec 2024969.5
16 Dec 2024988
13 Dec 2024978.35
12 Dec 2024975.65
11 Dec 2024986.3
10 Dec 2024974.7
09 Dec 2024982.9

Historical Revenue of Zydus Lifesciences Ltd

No data available

* All values are in crore

Historical EBITDA of Zydus Lifesciences Ltd

No data available

* All values are in crore

Historical Net Profit of Zydus Lifesciences Ltd

No data available

* All values are in crore

Zydus Lifesciences Ltd News Hub

News

Zydus Life gets USFDA nod for Lidocaine and Prilocaine Cream USP

Lidocaine and Prilocaine Cream USP is indicated as a topical anaesthetic for use on normal...

Read more

19 Dec 2024 12:49

News

Zydus Lifesciences receives USFDA approval for Lidocaine and Prilocaine Cream

Zydus Lifesciences has received final approval from the United States Food and Drug Admini...

Read more

19 Dec 2024 14:58

News

Zydus Animal Health and Investment to divest its stake held in Mylan

Zydus Lifesciences announced that Zydus Animal Health and Investments, a wholly owned subs...

Read more

16 Dec 2024 12:50

News

Zydus Lifesciences Ltd spurts 1.03%, rises for third straight session

Zydus Lifesciences Ltd rose for a third straight session today. The stock is quoting at Rs...

Read more

03 Dec 2024 13:06

News

Zydus Lifesciences receives Rs 1.61-cr GST demand for FY 2017-18

The issue pertains to the Input Tax Credit (ITC) carried forward through the TRAN-1 form. ...

Read more

29 Nov 2024 12:04

News

Zydus Life Q2 PAT rises 14% YoY to Rs 911 cr

Revenue from operations grew 19.87% year on year (YoY) to Rs 5,237 crore in the quarter en...

Read more

12 Nov 2024 15:22

Document

Annual Reports

Annual Report 2024

dropdown
download

Credit Ratings

Credit Report 2024

dropdown
download

Concalls

Sep 2021

Transcript

Jan 2021

PPT

Aug 2020

PPT

Feb 2020

PPT

FAQs for Quarterly Results of Zydus Lifesciences Ltd

What key financial metrics are included in Zydus Lifesciences Ltd's quarterly results?

Key financial metrics in Zydus Lifesciences Ltd's quarterly results typically include revenue, net profit, earnings per share (EPS), and operating margins. Other metrics might include cash flow, operating expenses, and client metrics.

When does Zydus Lifesciences Ltd announce its quarterly results?

Zydus Lifesciences Ltd usually announces its quarterly results around mid-July for Q1, mid-October for Q2, mid-January for Q3, and mid-April for Q4, aligning with the end of each fiscal quarter. However, different finance companies have their respective schedules for announcing their quarterly results.

How does Zydus Lifesciences Ltd's quarterly performance impact its stock price?

Zydus Lifesciences Ltd's quarterly performance can lead to stock price volatility, with strong results often driving the price up, while disappointing results can cause it to drop. Investor sentiment and market expectations also play significant roles.

What is the impact of Zydus Lifesciences Ltd's quarterly results on dividends?

The impact of Zydus Lifesciences Ltd's quarterly results on dividends can influence dividend decisions, with strong performance potentially leading to increased or special dividends, while weaker results might result in stable or reduced dividends.

Are there any special announcements usually made during Zydus Lifesciences Ltd's quarterly results?

Yes, Zydus Lifesciences Ltd often makes special announcements during its quarterly results, including strategic updates, key client wins, and major contract renewals. They might also guide future performance and share insights on industry trends. These updates are typically highlighted in their press release. However, special announcements made during quarterly results may vary from company to company.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Demat Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Demat Account
Verify your phone
+91
*By signing up you agree to our terms & conditions